Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was found to be safe in children aged 5 to 11 years in a late-stage study and generated a strong immune response in them, bringing the prospect of broader vaccination coverage closer.

Pfizer said it would share the results with regulators in the U.S. and other countries and seek emergency use authorization in the U.S. as early as the end of the month.



Source link

By EDONS